Header cover image
  • Investing Ideas
  • Mexican Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Mexican Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Genomma Lab Internacional. de

Market Cap: Mex$18.0b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

LAB B

Mex$18.44

7D

1.8%

1Y

-18.3%